Status:
RECRUITING
Visual Function Abnormalities in Strabismus and Amblyopia and Response to Therapy
Lead Sponsor:
The Cleveland Clinic
Conditions:
Amblyopia
Strabismus
Eligibility:
All Genders
6-90 years
Brief Summary
Amblyopia and strabismus are characterized by a reduction in visual acuity, contrast sensitivity, grating acuity, vernier acuity, reading difficulties and binocular visual function deficits. Treated p...
Detailed Description
To examine the response of therapy on visual functions in amblyopic and strabismic participants. The following visual functions will be measured prior to treatment. Eye movements, contrast sensitivit...
Eligibility Criteria
Inclusion
- History of amblyopia or presence of amblyogenic risk factors.
Exclusion
- History of neurologic disorders
Key Trial Info
Start Date :
February 21 2020
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
March 12 2027
Estimated Enrollment :
150 Patients enrolled
Trial Details
Trial ID
NCT04310241
Start Date
February 21 2020
End Date
March 12 2027
Last Update
May 22 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Cleveland Clinic
Cleveland, Ohio, United States, 44195